Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy care continuum communication

	Profile	Recent Articles on Subject
1	Kristen Monaco MedPage Today	ADHD Drug Recall; Alcohol and Sports Gambling; Deprescribing Benzodiazepines - about 1 month ago
2	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: FDA scolds drugmaker over promotion that touts ‘misleading’ comparison with generics - about 2 months ago STAT+: Pharmalittle: We’re reading about an FDA hold on an Amgen obesity drug, imported Canadian drugs, and more - 2 months ago STAT+: Pharmalittle: We’re reading about a Merck deal for an obesity pill, a departing FDA official, and more - 4 months ago STAT+: Pharmalittle: We’re reading about a key Merck drug trial, cheap Wegovy in China, and more - 5 months ago STAT+: Pharmalittle: We’re reading about a Merck drug-label controversy, Astellas pulling an application, and more - 6 months ago STAT+: Pharmalittle: We’re reading about Bavarian Nordic’s mpox shot, a crackdown on Ozempic prescribing and more - 7 months ago STAT+: Pharmalittle: We’re reading about FTC scrutiny of a Novo deal, a Genentech reorganization, and more - 8 months ago STAT+: Pharmalittle: We’re reading about FDA rejecting MDMA; a nasal spray for allergic reactions, and more - 8 months ago STAT+: Pharmalittle: We’re reading about a European probe into vaccine talks; net drug prices falling, and more - about 1 year ago STAT+: Pharmalittle: We’re reading about Europe’s pharma reform, weight-loss meds, and more - about 1 year ago STAT+: Pharmalittle: We’re reading about a liver-drug approval, pharma’s positive outlook, and more - about 1 year ago STAT+: Pharmalittle: We’re reading about Amazon delivering Zepbound, hemophilia treatments, and more - about 1 year ago STAT+: Pharmalittle: We’re reading about Ozempic tackling kidney disease, OTC birth control, and more - about 1 year ago STAT+: Pharmalittle: We’re reading about a nixed Medicare negotiation lawsuit, an Obamacare challenge, and more - about 1 year ago STAT+: Many costly generic drugs are unavailable at Amazon, Cuban, and other alternative pharmacies - about 1 year ago STAT+: Pharmalittle: We’re reading about state moves on drug pricing, an asthma med for kids and more - about 1 year ago STAT+: Pharmalittle: We’re reading about a pharma job slowdown, diet drugs boosting GDP, and more - about 1 year ago STAT+: Pharmalittle: We’re reading about weight loss drugs, a cell therapy for melanoma, and more - about 1 year ago STAT+: Pharmalittle: We’re reading about a U.S. vaccine panel, an abortion pill, and much more - about 1 year ago STAT+: Pharmalittle: We’re reading about drug price hikes, Bayer strategic moves, and more - over 1 year ago STAT+: Pharmalittle: We’re reading about Lilly selling drugs directly, UCB leaving BIO, and more news - over 1 year ago STAT+: Pharmalittle: FDA approvals rebound, abortion pill orders rise, and more news - over 1 year ago STAT+: Pharmalittle: Drugmakers raise prices, pharmacies fear fees, McKinsey settles - over 1 year ago STAT+: Pharmalittle: U.S. to impose inflation penalties on dozens of drugmakers; Supreme Court will decide abortion pill access - over 1 year ago STAT+: Pharmalittle: Employers hire virtual providers as obesity drug gatekeepers; Vertex non-opioid nerve pain drug succeeds in mid-stage trial - over 1 year ago STAT+: Pharmalittle: Sanofi scraps rare-disease drug deal under FTC pressure; patients regain weight after stopping Lilly’s Zepbound - over 1 year ago STAT+: Pharmalittle: More U.S. states and cities are suing insulin makers; Biden looks to boost U.S. drug manufacturing amid shortages - over 1 year ago STAT+: Pharmalittle: U.K. approves world’s first CRISPR-based medicine; FDA to review pricey cancer drug lacking confirmatory data - over 1 year ago STAT+: Pharmalittle: FTC challenges ‘inaccurately or improperly’ listed patents; Elliott builds stake in BioMarin - over 1 year ago STAT+: Pharmalittle: Vertex and U.K. at odds over value of CF meds; French authorities probe Sanofi over alleged market manipulation - over 1 year ago STAT+: Pharmalittle: U.S. Senate eyes more policies for regulating PBMs; Novo claims most U.S. Wegovy patients pay less than $25 a month - over 1 year ago STAT+: Pharmalittle: Sarepta Duchenne therapy misses primary endpoint; FDA holds panel for first CRISPR treatment for sickle cell - over 1 year ago STAT+: Pharmalittle: Pharma likely to expand legal attacks on Medicare negotiations; CDC recommends rationing RSV drug - over 1 year ago STAT+: Pharmalittle: Pharma moves closer to a pricing deal with U.K.; FDA to review AstraZeneca request for self-administered flu vax - over 1 year ago STAT+: Pharmalittle: China arrests an Astellas exec accused of spying; weight-loss drugs are being tested in children - over 1 year ago STAT+: Pharmalittle: Weight-loss drugs fuel boom for firms that fill syringes; employers that cover obesity drug may double in 2024 - over 1 year ago STAT+: Pharmalittle: More than 9 in 10 pharmacy techs report drug shortages; Yale and VA strike deal over ketamine patent royalties - over 1 year ago STAT+: Pharmalittle: Lilly sues spas and compounders over ‘unapproved’ Mounjaro; nasal-spray EpiPen alternative suffers setback - over 1 year ago STAT+: Lilly sues compounders, wellness centers and spas over unapproved versions of Mounjaro - over 1 year ago
3	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	3 closely watched drugs that failed in the clinic - 4 months ago Is anyone taking the world’s priciest drugs? - 8 months ago Neuro drugs are still faltering, despite rising investment - 9 months ago
4	Associated Press MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Better Drugs Through AI? What Machine Learning Can Teach Big Pharma. - 5 months ago
5	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	The first MASH drug could open the door for others — including GLP-1s - 5 months ago BMS’ KarXT nears schizophrenia approval, but AbbVie and others wait in the wings - 8 months ago 3 Big Pharma cancer drugs facing inflation penalties - 9 months ago Cutting pills. Rationing insulin. How Americans struggle to pay for drugs. - about 1 year ago
6	Beth Mole Ars Technica Senior Health Reporter @ArsTechnica. microbiologyinfectious diseasespublic health	Drugmaker shut down after black schmutz found in injectable weight-loss drug - 6 months ago
7	Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile educationpolitics	Will a Medicare boost propel digital therapeutics to the mainstream? - 6 months ago With a rise in animal-human organ transplants, a drugmaker aims for a new standard of care - about 1 year ago
8	N. Adam Brown MD MedPage Today Healthcare Strategist/Communicator. Washington, D.C. Healthcarestrategycommunication	Direct-to-Consumer Drugs: Big Pharma's Digital Health Play - 7 months ago
9	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Pharmacy Focus: Alzheimer Drug Pipeline Expands, Promising Therapies in Development - 8 months ago Key Market Trends for the Current Specialty Drug Pipeline - over 1 year ago Survey: 72% of Pharmacy Technicians’ Workflow Affected by Drug Shortages - over 1 year ago
10	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	STAT+: When a cancer drug fails, oncologists often fly blind. A precision technique might light the way - about 1 year ago

Journalists covering medical drugs